We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Konsensus-Statement - Schlaganfallprophylaxe bei nicht-valvulärem Vorhofflimmern unter besonderer Berücksichtigung der direkten oralen Antikoagulanzien.
- Authors
Pabinger, Ingrid; Lang, Wilfried; Roithinger, Franz Xaver; Weidinger, Franz; Eichinger-Hasenauer, Sabine; Glehr, Reinhold; Halbmayer, Walter-Michael; Haring, Hans-Peter; Jilma, Bernd; Korninger, Hans Christian; Kozek-Langenecker, Sibylle; Kyrle, Paul; Watzke, Herbert; Weltermann, Ansgar; Willeit, Johann; Huber, Kurt
- Abstract
The introduction of new direct oral anticoagulants has changed the treatment of nonvalvular atrial fibrillation. However, these changes are not yet fully reflected in current guidelines.This consensus statement, endorsed by six Austrian medical societies, provides guidance to current prophylacticapproaches of thromboembolic events in nonvalvular atrial fibrillation on the basis of current evidence and published guidelines. Furthermore, some special subjects are treated, like changes in laboratory parameters and their interpretation under treatment with direct oral anticoagulants, treatment of bleedings, approach to operations, cardioversion and ablation, and specific neurological aspects. For a CHADS-VASc-Score of ≥ 2, anticoagulation is recommended with a high level of evidence (1A). At the end of the consensus statement, recommendations for a number of specific patient subgroups can be found, in order to help treating physicians to arrive at appropriate therapeutic decisions.
- Subjects
ANTICOAGULANTS; ATRIAL fibrillation treatment; GUIDELINES; MEDICAL societies; DECISION making in clinical medicine; EVIDENCE-based medicine
- Publication
Wiener Klinische Wochenschrift, 2014, Vol 126, Issue 23/24, p792
- ISSN
0043-5325
- Publication type
Report
- DOI
10.1007/s00508-014-0586-5